Moderna COVID-19 vaccine clears key safety hurdle in mouse study

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

A study of Moderna Inc’s COVID-19 vaccine in mice lends some assurance that it will not increase the risk of more severe disease, and that one dose may provide protection against the novel coronavirus, according to preliminary data released on Friday.

Prior studies on a vaccine for SARS – a close cousin to the new virus that causes COVID-19 – suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the pathogen, especially in individuals who do not produce an adequately strong immune response.

Scientists have seen this risk as a key hurdle that must be cleared before vaccines can be safely tested in thousands of healthy people.

While the data released by the U.S. National Institutes of Allergy and Infectious Disease (NIAID) and Moderna was encouraging, mouse data is no guarantee of what will happen in humans.

The vaccine is currently in midstage testing in healthy volunteers. Moderna said on Thursday it plans to begin final-stage trials enrolling 30,000 people in July.

In the new study, six-week-old mice received one or two shots of a variety of doses of Moderna’s vaccine, including doses considered not strong enough to elicit a protective immune response. Researchers then exposed the mice to the virus.

Subsequent analyses looking for signs of disease enhancement suggests that “sub-protective” immune responses do not cause what is known as vaccine-associated enhanced respiratory disease, a susceptibility to more severe disease in the lungs.

“Subprotective doses did not prime mice for enhanced immunopathology following (exposure),” Dr. Barney Graham of the Vaccine Research Center at NIAID and colleagues wrote in the not yet peer reviewed manuscript, posted on the bioRxiv website.

Further testing also suggested that the vaccine induces potent neutralizing antibody responses – the type of response needed to block the virus from infecting cells.

This article was originally posted on finance.yahoo.com/news/.
Home of Science
Follow me

- Advertisement -

Discover

Sponsor

Latest

Bill that could delist Chinese companies from U.S. stock exchanges to see ‘swift passage’ in House, analyst says

Momentum is building for the Democratic-run House to approve sweeping legislation that could ultimately bar many Chinese companies from listing their shares on U.S....

‘We are living the future right now’ — ‘Shark’ Robert Herjavec says work-from-home here to stay

KEY POINTS  “Shark Tank” investor Robert Herjavec said people should not underestimate the long-term effects of the coronavirus pandemic on remote working. “We have been...

What Are the Different Kinds of Features That You Can Get From Netflix?

You can add movies to your Netflix account, but you can also have several different kinds of features. Every Netflix member gets the same...

Be More Like Oprah – Part 4

The word Oprah means a lady in an elite position. But what does that mean to a guy? Can he be one too? ...

Coronavirus erases almost all the 23 million new jobs created since the Great Recession

It took 10 years for the U.S. economy to create 23 million new jobs. It took the coronavirus pandemic just a month to destroy...
Home of Science
Follow me